In the literature, relatively high HER4 expression has been correlated with estrogen receptor-positive, low-grade, and slowly proliferating breast cancers, while in oestrogen receptor-negative cases, expression of HER4 tends to be downregulated [82]. Here, ERBB4 is linked to breast carcinoma.